{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T06:31:16Z","timestamp":1785047476757,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.ejogrb.2006.10.013","type":"journal-article","created":{"date-parts":[[2006,11,20]],"date-time":"2006-11-20T10:44:16Z","timestamp":1164019456000},"page":"61-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Treatment of polycystic ovary syndrome with spironolactone plus licorice"],"prefix":"10.1016","volume":"131","author":[{"given":"Decio","family":"Armanini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Castello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Scaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guglielmo","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianbattista","family":"Faccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Pellati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bertoldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Moghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2006.10.013_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2265.1978.tb03578.x","article-title":"Endocrine effects of spironolactone in man","volume":"9","author":"Tidd","year":"1978","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1210\/jcem-66-1-208","article-title":"Side effects of spironolactone therapy in the hirsute woman","volume":"66","author":"Helfer","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0015-0282(16)59346-7","article-title":"The endocrine effects of spironolactone used as an antiandrogen","volume":"48","author":"Young","year":"1987","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.7326\/0003-4819-85-5-630","article-title":"Spironolactone and endocrine dysfunction","volume":"85","author":"Loriaux","year":"1976","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2265.1985.tb01090.x","article-title":"In vivo metabolites of spironolactone and potassium canrenoate: determination of potential anti-androgenic activity by mouse kidney cytosol receptor assay","volume":"23","author":"Armanini","year":"1985","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.hdx.0000089783.30450.cb","article-title":"Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure","volume":"5","author":"Moore","year":"2003","journal-title":"Heart Dis"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib7","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1210\/jc.2003-031780","article-title":"Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: open-labeled study","volume":"89","author":"Ganie","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib8","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1210\/jcem-68-5-966","article-title":"Spironolactone is an effective and well-tolerated systemic antiandrogen therapy for hirsute women","volume":"68","author":"Barth","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib10","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19\u201325.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib11","first-page":"89","article-title":"Comparison of spironolactone, flutamide and finasteride efficacy in the treatment of hirsutism: a randomized, double-blind, placebo-controlled trial","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0015-0282(16)48972-7","article-title":"The effects of spironolactone on adrenal steroidogenesis in hirsute women","volume":"44","author":"Serafini","year":"1985","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib13","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1210\/endo-94-6-1628","article-title":"Spironolactone and testicular cytochrome P450 decreases testosterone formation in several species and changes in hepatic drug metabolism","volume":"94","author":"Menard","year":"1974","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000298915","article-title":"Androgen receptors in hirsutism and acne","volume":"22","author":"Schmidt","year":"1986","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/1523-1747.ep12261252","article-title":"Differential rates of conversion of testosterone to dihydrotestosterone in acne and in normal human skin: a possible pathogenetic factor in acne","volume":"56","author":"Sansone","year":"1971","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib16","first-page":"952","article-title":"The insulin resistance in women with hyperandrogenism is partially reversed by anti-androgen treatment: evidence that androgens impair insulin action in women","volume":"81","author":"Moghetti","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1210\/jcem-47-3-691","article-title":"Oral progestational activity of spironolactone","volume":"47","author":"Shane","year":"1978","journal-title":"J Clin Endocrnol Metab"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0015-0282(16)60807-5","article-title":"Absence of progestational activity of oral spironolactone","volume":"52","author":"Nakajima","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1210\/jcem-51-3-429","article-title":"A novel use of spironolactone: treatment of hirsutism","volume":"51","author":"Shapiro","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib20","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(87)91014-2","article-title":"Mineralocorticoid activity of licorice: 11-hydroxysteroid dehydrogenase deficiency comes of age","volume":"2","author":"Stewart","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib21","first-page":"606","article-title":"Affinity of licorice derivatives for mineralocorticoid and glucocorticoid receptors","volume":"16","author":"Armanini","year":"1983","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib22","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/BF03349029","article-title":"Further studies on the mineralocorticoid action of licorice in humans","volume":"19","author":"Armanini","year":"1996","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib23","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1056\/NEJM199910073411515","article-title":"Licorice reduced serum testosterone in men","volume":"341","author":"Armanini","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib24","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.steroids.2004.09.005","article-title":"Licorice reduces serum testosterone in healthy women","volume":"69","author":"Armanini","year":"2004","journal-title":"Steroids"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib25","first-page":"939","article-title":"Effect of traditional herbal medicine on serum testosterone levels and its induction of regular ovulation in hyperandrogenic and oligomenorrheic women","volume":"34","author":"Yaginuma","year":"1982","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib26","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1142\/S0192415X91000119","article-title":"Effect of paeoniflorin, glycyrrhizin and glycyrrhetic acid on ovarian androgen production","volume":"19","author":"Takeuchi","year":"1991","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1507\/endocrj1954.35.333","article-title":"Inhibitory effect of glycyrrhetinic acid on testosterone production in rat gonads","volume":"35","author":"Sakamoto","year":"1988","journal-title":"Endocrinol Japon"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib28","first-page":"789","article-title":"Effect of a traditional herbal medicine (Shakuyaku-kanzo-to) on testosterone secretion in patients with polycystic ovary syndrome detected by ultrasound","volume":"4","author":"Takahashi","year":"1988","journal-title":"Nippon Sanka Fujinka Gakkai Zasshi"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib29","first-page":"47","article-title":"Effect of glycyrrhetinic acid and its derivatives 5\u03b1 and 5\u03b2 reductase in rat liver","volume":"229","author":"Tamura","year":"1979","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2002-34587","article-title":"History of the endocrine effects of licorice","volume":"110","author":"Armanini","year":"2002","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0960-0760(01)00093-0","article-title":"Estrogen-like activity of glabrene and other constituents isolated from licorice root","volume":"78","author":"Tamir","year":"2001","journal-title":"J Ster Biochem Mol Biol"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib32","first-page":"217","article-title":"GCL analysis of ammonium glycyrrhizinate","volume":"117","author":"Ventura","year":"1978","journal-title":"Boll Chim Farm"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/clinchem\/31.4.637","article-title":"Steroid profiling: an update","volume":"31","author":"Schmidt","year":"1985","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/s-2003-42724","article-title":"Licorice consumption and serum testosterone in healthy man","volume":"111","author":"Armanini","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00004872-200401000-00011","article-title":"Fibrosis in hypertensive heart disease: focus on cardiac fibroblasts","volume":"22","author":"Weber","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib36","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1210\/jc.2003-031545","article-title":"Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes","volume":"89","author":"Calo","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib37","first-page":"1627","article-title":"Spironolactone: a glucocorticoid agonist or antagonist?","volume":"4","author":"Campen","year":"1982","journal-title":"Clin Exp Hypertens A"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1530\/eje.0.1440087","article-title":"Clinical implications of glucocorticoid metabolism by 11\u03b2-hydroxysteroid dehydrogenase in target tissues","volume":"144","author":"Quinkler","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib39","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/BF03347023","article-title":"Effect of licorice on the reduction of body fat mass in healthy subjects","volume":"26","author":"Armanini","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib40","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.steroids.2005.01.007","article-title":"Glycyrrhetinic acid, the active principle of licorice, can reduce the thickness of subcutaneous thigh fat through topical application","volume":"70","author":"Armanini","year":"2005","journal-title":"Steroids"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib41","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3109\/00016348609157034","article-title":"Inhibition by plant herb extracts of steroid binding in uterus, liver and serum of the rabbit","volume":"65","author":"Tamaya","year":"1986","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib42","first-page":"620","article-title":"Estrogenic effect of licorice rot","volume":"25","author":"Van Hulle","year":"1969","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib43","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1507\/endocrj1954.14.34","article-title":"Effect of glycyrrhizin on estrogen action","volume":"14","author":"Kumagai","year":"1967","journal-title":"Endocrinol Japon"},{"key":"10.1016\/j.ejogrb.2006.10.013_bib44","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1677\/joe.0.0840371","article-title":"Interaction of spironolactone with oestradiol receptors in cytosol","volume":"84","author":"Lewy","year":"1980","journal-title":"J Endocrinol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121150600563X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121150600563X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:16:19Z","timestamp":1759554979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030121150600563X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S030121150600563X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2006.10.013","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of polycystic ovary syndrome with spironolactone plus licorice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2006.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}